Drug coated balloons and bare metal stents in ST-elevation myocardial infarction: eternal life or return of the living dead?
作者信息
Farah Ahmed, Jeger Raban V
机构信息
Knappschaftskrankenhaus Dortmund, Klinikum Westfalen, Dortmund, Germany.
Triemli Hospital Zürich, Zürich, Switzerland, and University of Basel, Basel, Switzerland.
出版信息
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):773-776. doi: 10.21037/cdt-2023-4. Epub 2023 Aug 22.
Abstract
摘要
相似文献
1
Drug coated balloons and bare metal stents in ST-elevation myocardial infarction: eternal life or return of the living dead?
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):773-776. doi: 10.21037/cdt-2023-4. Epub 2023 Aug 22.
2
Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study).
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):792-804. doi: 10.21037/cdt-22-623. Epub 2023 Oct 17.
3
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
JACC Cardiovasc Interv. 2014 Jan;7(1):55-63. doi: 10.1016/j.jcin.2013.07.012. Epub 2013 Dec 11.
4
The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
JACC Cardiovasc Interv. 2014 Jan;7(1):64-71. doi: 10.1016/j.jcin.2013.09.006. Epub 2013 Dec 11.
5
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial.
EuroIntervention. 2020 Apr 17;15(17):1527-1533. doi: 10.4244/EIJ-D-19-00723.
6
Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
J Am Coll Cardiol. 2013 Aug 6;62(6):496-504. doi: 10.1016/j.jacc.2013.05.022. Epub 2013 Jun 7.
7
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
JACC Cardiovasc Interv. 2011 Jan;4(1):24-9. doi: 10.1016/j.jcin.2010.11.003.
8
Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents.
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):768-772. doi: 10.21037/cdt-23-297. Epub 2023 Sep 20.
9
Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.
Circ Cardiovasc Interv. 2016 Oct;9(10). doi: 10.1161/CIRCINTERVENTIONS.116.003670.
10
Factors Associated With the Use of Bare Metal Stents in Patients With ST Elevation Myocardial Infarction.
Cardiovasc Revasc Med. 2020 Dec;21(12):1489-1492. doi: 10.1016/j.carrev.2020.05.008. Epub 2020 May 15.
本文引用的文献
1
Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study).
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):792-804. doi: 10.21037/cdt-22-623. Epub 2023 Oct 17.
2
Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI.
JACC Cardiovasc Interv. 2023 Apr 10;16(7):771-779. doi: 10.1016/j.jcin.2023.01.380.
3
Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
J Invasive Cardiol. 2022 Jan;34(1):E39-E42. doi: 10.25270/jic/20.00741. Epub 2021 Nov 18.
4
Factors Influencing 1st and 2nd Generation Drug-Eluting Stent Performance: Understanding the Basic Pharmaceutical Drug-in-Polymer Formulation Factors Contributing to Stent Thrombosis Do We Really Need to Eliminate the Polymer?
J Pharm Pharm Sci. 2021;24:435-461. doi: 10.18433/jpps32053.
5
Early coronary healing in ST segment elevation myocardial infarction: sirolimus-eluting stents vs. drug-coated balloons after bare-metal stents. The PEBSI-2 optical coherence tomography randomized study.
Coron Artery Dis. 2021 Dec 1;32(8):673-680. doi: 10.1097/MCA.0000000000001038.
6
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.
JACC Cardiovasc Interv. 2021 Mar 22;14(6):639-648. doi: 10.1016/j.jcin.2020.12.011.
7
Hard Events AfteR Orsiro Sirolimus-Eluting Stent (HEROES) in STEMI: A Multicenter Registry.
J Invasive Cardiol. 2020 Dec;32(12):E331-E337. doi: 10.25270/jic/20.00265. Epub 2020 Nov 22.
8
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
9
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
10
Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):411-420. doi: 10.1002/ccd.28798. Epub 2020 Mar 21.
Zotero 插件